Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. | Cell Adh Migr | 2023 | 37726886 | PubTator, text mining | PubMed |
| Clinical and Biological Characteristics of 14 Adult Cases of NUP98-NSD1+ Acute Myeloid Leukemia | Turk J Haematol | 2023 | 37723856 | PubTator, text mining | PubMed |
| Histone mutations in cancer. | Biochem Soc Trans | 2023 | 37721138 | PubTator, text mining | PubMed |
| Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic-associated molecular subtypes and genomic mutations. | Front Pharmacol | 2023 | 37719859 | PubTator, text mining | PubMed |
| Molecular mechanism underlying epithelial-mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma. | Thorac Cancer | 2023 | 37718469 | PubTator, text mining | PubMed |
| Osteosarcoma's genetic landscape painted by genes' mutations. | Acta Biochim Pol | 2023 | 37717265 | PubTator, text mining | PubMed |
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial). | BMC Cancer | 2023 | 37710198 | PubTator, text mining | PubMed |
| Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma. | Cell Rep | 2023 | 37708024 | PubTator, text mining | PubMed |
| TAOK3 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance Through Augmenting Autophagy Mediated by IRGM. | Adv Sci (Weinh) | 2023 | 37705061 | PubTator, text mining | PubMed |
| Single-cell brain organoid screening identifies developmental defects in autism. | Nature | 2023 | 37704762 | PubTator, text mining | PubMed |
| Early-Stage Breast Cancer Detection in Breast Milk. | Cancer Discov | 2023 | 37704212 | PubTator, text mining | PubMed |
| CRISPR screens in sister chromatid cohesion defective cells reveal PAXIP1-PAGR1 as regulator of chromatin association of cohesin. | Nucleic Acids Res | 2023 | 37702151 | PubTator, text mining | PubMed |
| Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary-pancreatic cancers. | J Gastroenterol | 2023 | 37698719 | PubTator, text mining | PubMed |
| KMT2C expression and DNA homologous recombination repair factors in lung cancers with a high-grade fetal adenocarcinoma component. | Transl Lung Cancer Res | 2023 | 37691868 | PubTator, text mining | PubMed |
| A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer. | Cancer Res Commun | 2023 | 37691854 | PubTator, text mining | PubMed |
| Patient-Derived Organoids as a Promising Tool for Multimodal Management of Sarcomas. | Cancers (Basel) | 2023 | 37686615 | PubTator, text mining | PubMed |
| An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma. | Front Oncol | 2023 | 37681027 | PubTator, text mining | PubMed |
| Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia. | Blood Cancer J | 2023 | 37673866 | PubTator, text mining | PubMed |
| To stay in shape and keep moving: MLL emerges as a new transcriptional regulator of Rho GTPases. | Small GTPases | 2023 | 37671980 | PubTator, text mining | PubMed |
| RAIDS atlas of significant genetic and protein biomarkers in cervical cancer. | J Gynecol Oncol | 2023 | 37668079 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=23